{"id":"https://genegraph.clinicalgenome.org/r/bf233434-4aa5-44b0-8972-f913847305e7v1.0","type":"EvidenceStrengthAssertion","dc:description":"GABRG2 was first reported in relation to autosomal dominant epilepsy as early as 2001 (Baulac et al., Wallace et al.; PMID: 11326274, 11326275). Eight unique variants (missense, nonsense, and splice site) are included in this curation to maximize the score for genetic evidence; however, more probands are available in the literature (PMID: 11326274, 12117362, 27066572, 27864268, 28460589, 31004928). Evidence supporting this gene-disease relationship includes case-level data, segregation data, and experimental data. Proband phenotypes included febrile seizures, complex partial seizures, childhood absence epilepsy, GEFS+, epileptic encephalopathy, epilepsy of infancy with migrating focal seizures, Lennox-like epilepsy, and Lennox-Gastaut syndrome. While these phenotypes exist on a spectrum, the Epilepsy GCEP decided to lump these conditions under the general term for epilepsy until more evidence is available. Variants in this gene segregated with disease in 16 additional family members across 3 families (PMID: 11326274, 12117362, 27066572). This gene-disease association is supported by multiple mouse models. In summary, GABRG2 is definitively associated with autosomal dominant epilepsy.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/bf233434-4aa5-44b0-8972-f913847305e7","GCISnapshot":"https://genegraph.clinicalgenome.org/r/3a3176e9-ac0c-41fe-ae40-0750726c33d8","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/3a3176e9-ac0c-41fe-ae40-0750726c33d8_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2020-09-01T00:00:00Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/3a3176e9-ac0c-41fe-ae40-0750726c33d8_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10005","date":"2020-01-21T17:00:00.000Z","role":"Approver"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3a3176e9-ac0c-41fe-ae40-0750726c33d8_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3a3176e9-ac0c-41fe-ae40-0750726c33d8_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8dbc3b3a-64fd-4a25-b4c0-cc75718084e3","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c2a802e0-1241-49d5-8710-66e31be12aa4","type":"Finding","dc:description":"Spike-and-wave discharges on lectrocorticograms and behavioral arrest displayed by knockout mice were consistent with childhood absence seizurs in humans.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23408872","rdfs:label":"Heterozygous knockout mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/01bf0939-fc69-4d07-a5b4-4c98ce1a3da3","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/08e2c520-6ddd-4b09-8631-e464b7eb1212","type":"Finding","dc:description":"The GABRG2 Q390X mutation is associated with a GEFS+ phenotype in humans. Knock-in mice had spontaneous generalized tonic-clonic seizures, myoclonic jerks, and increased mortality throughout life, including spontaneous death. They were also hyperactive and engaged in less social interactions with novel mice. Both knockout and knock-in mice had impaired spatial memory and cognitive deficits as shown by a Barnes maze test.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27340224","rdfs:label":"Q390X heterozygous knockin mice","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/3a3176e9-ac0c-41fe-ae40-0750726c33d8_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3a3176e9-ac0c-41fe-ae40-0750726c33d8_ad_dn_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2ce9217c-a63a-404b-8afd-6cded66f9db8_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fcabac1a-e1de-4059-b61f-92f979a99400","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31004928","rdfs:label":"Patient 2","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":2,"detectionMethod":"NGS panel included 83 genes associated with epilepsy.","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Epilepsy of infancy with migrating focal seizures. Current seizures include clonic arm jerking on one side or in both legs (multiple times per day). Also presented with generalized hypotonia, poor sucking, and poor eye contact. EEG showed frequent multifocal epileptiform discharges and focal seizures that may spread to contralateral hemisphere.  MRI showed left perisylvian hyperfusion.","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2ce9217c-a63a-404b-8afd-6cded66f9db8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31004928","allele":{"id":"https://genegraph.clinicalgenome.org/r/bb5c2dd0-e0aa-479a-8f57-4ef3b05eaed3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NC_000005.10:g.162142311C>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362182271"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/bb51db5b-01f3-419e-beda-8a7e0f3b3eef_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/51f09838-bc78-4e1c-a568-8c639fb95c9b","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31004928","rdfs:label":"Patient 1","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":3,"detectionMethod":"","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Lennox-like epilepsy, profound developmental delay, dysmorphic features, poor eye contact, hypotonia.","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/bb51db5b-01f3-419e-beda-8a7e0f3b3eef_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31004928","allele":{"id":"https://genegraph.clinicalgenome.org/r/851aeb7e-db5b-4c09-a705-fcb19db18d74","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198903.2(GABRG2):c.964C>A (p.Pro322Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA314723"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/cb7db947-e002-4fdb-9fe1-eae7a7c98735_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Potential to upgrade for variant-level experimental evidence.","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2b88d2d7-be05-453b-b25a-59e342377a5f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27864268","rdfs:label":"Patient 8","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":1,"detectionMethod":"GeneDx clinical exome sequencing","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Daily tonic seizures beginning at 1 year. Some improvement with levetiracetam, but seizures persist. EEG showed excess diffuse beta activity and intermittent left temporal slowing, poor organization, and frequent sharps maximal at the central vertex. Has severe global delay and is non-verbal. Also presents with hypotonia and intermittent hand posturing. MRI shows falx hypoplasia.","phenotypes":"obo:HP_0200134","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/cb7db947-e002-4fdb-9fe1-eae7a7c98735_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27864268","allele":{"id":"https://genegraph.clinicalgenome.org/r/5b47edc4-a8bd-40cc-92e7-3d6ff4c95eef","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198903.2(GABRG2):c.1147T>C (p.Phe383Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA362182517"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/62c55409-54a8-464b-a99c-8cbcd9d6b11c_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9987b6a5-efdb-4757-9332-bc0de3394c21","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28460589","rdfs:label":"Patient 4","ageType":"AgeAtOnset","ageUnit":"Days","ageValue":1,"detectionMethod":"","firstTestingMethod":"Exome sequencing","phenotypeFreeText":"At birth, presented with generalized convulsions and hypotonia. By 7 months, had persistent myoclonic seizures. Displayed abnormal eye movements and delayed visual maturity for the first 2 years of life. Seizures started again at 12y; at 13y she had complex partial seizures 4-5 times per month with smile, drooling and head turn.","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/62c55409-54a8-464b-a99c-8cbcd9d6b11c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28460589","allele":{"id":"https://genegraph.clinicalgenome.org/r/84a24b01-095c-4978-99b3-89e421869774","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198903.2(GABRG2):c.316G>A (p.Ala106Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA314712"}},"alleleOrigin":{"id":"cg:DeNovoAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADDeNovoCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallAutosomalDominantDeNovoVariantEvidenceCriteria","strengthScore":8},{"id":"https://genegraph.clinicalgenome.org/r/3a3176e9-ac0c-41fe-ae40-0750726c33d8_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/117cd6fd-efc8-4735-91a5-464f86e345d8_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/49b8a319-3aa7-40ac-91c3-23b8b68987b5","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27066572","rdfs:label":"III-10","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Febrile seizures","phenotypes":"obo:HP_0002373","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Sanger sequencing","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/117cd6fd-efc8-4735-91a5-464f86e345d8_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27066572","allele":{"id":"https://genegraph.clinicalgenome.org/r/40a4621c-c997-4876-b49d-b578dcd4e642","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198903.2(GABRG2):c.406C>T (p.Arg136Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/205540"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/cb2d0abf-d117-4df1-9a06-84313af6f5a2_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Downgraded due to candidate gene sequencing.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bc5a0731-4d9b-4cfe-a53f-893d297adc1a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12117362","rdfs:label":"II-1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":4,"detectionMethod":"Candidate gene sequencing of GABRG2 was used.","firstTestingMethod":"PCR","phenotypeFreeText":"Typical CAE and 3 febrile convulsions starting at 4 years. 1 GTCS per year at 10 and 11 years. EEG showed 3/s generalized SWD during resting as well as photosensitivity.","previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Restriction digest","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/cb2d0abf-d117-4df1-9a06-84313af6f5a2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12117362","allele":{"id":"https://genegraph.clinicalgenome.org/r/0cfedbf1-c4ba-4f58-878f-92c9393adafb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198903.2(GABRG2):c.889+2T>G","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/16210"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/3a3176e9-ac0c-41fe-ae40-0750726c33d8_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1d69d310-5a4d-4a5b-9df1-fbe6311024a6_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Kept at 0.5 points due to functional evidence.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/51036db9-1a04-4f88-b5b3-30030fbccb48","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11326274","rdfs:label":"III-4","ageType":"https://genegraph.clinicalgenome.org/r/","ageUnit":"https://genegraph.clinicalgenome.org/r/","detectionMethod":"Linkage analysis followed by exon sequencing of GABRG2","firstTestingMethod":"PCR","phenotypeFreeText":"Febrile seizures and afebrile epileptic seizures +","phenotypes":["obo:HP_0001250","obo:HP_0002373"],"previousTesting":false,"previousTestingDescription":"","secondTestingMethod":"Restriction digest","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/1d69d310-5a4d-4a5b-9df1-fbe6311024a6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11326274","allele":{"id":"https://genegraph.clinicalgenome.org/r/9717d176-8d7c-4b15-898a-72ea70ddff25","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198903.2(GABRG2):c.1103A>T (p.Lys368Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA126265"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8e8ca445-cddc-45c3-b5cd-29931b1f1459_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Kept at 0.5 points due to functional evidence from Huang et al. (PMID: 24798517).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1a96fa72-0015-4c0f-8097-d902231dbc00","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31004928","rdfs:label":"Patient 3","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":9,"detectionMethod":"","firstTestingMethod":"Next generation sequencing panels","phenotypeFreeText":"Diagnosed with Lennox-Gastaut syndrome. Seizures started as unprovoked generalized tonic-clonic, lasting up to 20 min, with atypical absence seizures as well. Also has autism spectrum disorder (regressive, beginning at 4 years) and language delay.","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/8e8ca445-cddc-45c3-b5cd-29931b1f1459_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/31004928","allele":{"id":"https://genegraph.clinicalgenome.org/r/0e7b58b7-ecda-417e-8332-2cd2ba1a594c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_198903.2(GABRG2):c.247C>T (p.Pro83Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA230804"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"}}}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/3a3176e9-ac0c-41fe-ae40-0750726c33d8_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/16348981-7c9f-4b17-9d78-f6b600a5ae54_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11326274","rdfs:label":"Baulac family","estimatedLodScore":3.61,"family":{"id":"https://genegraph.clinicalgenome.org/r/16348981-7c9f-4b17-9d78-f6b600a5ae54","type":"Family","rdfs:label":"Baulac family","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/51036db9-1a04-4f88-b5b3-30030fbccb48"}},"meetsInclusionCriteria":true,"phenotypeFreeText":"GEFS+ (FS, afebrile epileptic seizures, or both, with or without FS+)","phenotypeNegativeAlleleNegative":7,"phenotypePositiveAllelePositive":13,"proband":{"id":"https://genegraph.clinicalgenome.org/r/51036db9-1a04-4f88-b5b3-30030fbccb48"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/b1704ffc-aeaf-4484-a0cf-44c508e31c13_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/12117362","rdfs:label":"Kananura family","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/b1704ffc-aeaf-4484-a0cf-44c508e31c13","type":"Family","rdfs:label":"Kananura family","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/bc5a0731-4d9b-4cfe-a53f-893d297adc1a"}},"meetsInclusionCriteria":false,"phenotypeFreeText":"Febrile convulsions","phenotypeNegativeAlleleNegative":1,"phenotypePositiveAllelePositive":3,"phenotypes":"obo:HP_0002373","proband":{"id":"https://genegraph.clinicalgenome.org/r/bc5a0731-4d9b-4cfe-a53f-893d297adc1a"}},{"id":"https://genegraph.clinicalgenome.org/r/04bab65a-97d3-430a-8650-916a31e48f9f_proband_segregation","type":"FamilyCosegregation","dc:description":"Not enough segregations to include.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27066572","rdfs:label":"Family B","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/04bab65a-97d3-430a-8650-916a31e48f9f","type":"Family","rdfs:label":"Family B","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/49b8a319-3aa7-40ac-91c3-23b8b68987b5"}},"phenotypeFreeText":"10 affected, 7 of whom had febrile seizures.","phenotypeNegativeAlleleNegative":8,"phenotypePositiveAllelePositive":4,"phenotypes":"obo:HP_0002373","proband":{"id":"https://genegraph.clinicalgenome.org/r/49b8a319-3aa7-40ac-91c3-23b8b68987b5"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12}],"evidenceStrength":"Definitive","sequence":498,"specifiedBy":"GeneValidityCriteria7","strengthScore":16,"subject":{"id":"https://genegraph.clinicalgenome.org/r/rOoNM7N0pLA","type":"GeneValidityProposition","disease":"obo:MONDO_0005027","gene":"hgnc:4087","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_3a3176e9-ac0c-41fe-ae40-0750726c33d8-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}